Naihui Chu

1.2k total citations
52 papers, 741 citations indexed

About

Naihui Chu is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Naihui Chu has authored 52 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 38 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Naihui Chu's work include Tuberculosis Research and Epidemiology (40 papers), Mycobacterium research and diagnosis (33 papers) and Infectious Diseases and Tuberculosis (9 papers). Naihui Chu is often cited by papers focused on Tuberculosis Research and Epidemiology (40 papers), Mycobacterium research and diagnosis (33 papers) and Infectious Diseases and Tuberculosis (9 papers). Naihui Chu collaborates with scholars based in China, India and United States. Naihui Chu's co-authors include Hairong Huang, Yu Pang, Fengmin Huo, Mengqiu Gao, Bruno Gran, Hongfei Duan, Abdolmohamad Rostami, Jun An, Yang Li and Xiaoyou Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Scientific Reports.

In The Last Decade

Naihui Chu

51 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naihui Chu China 13 465 367 232 120 101 52 741
Hideo Ogata Japan 15 535 1.2× 613 1.7× 247 1.1× 39 0.3× 96 1.0× 77 884
Yaling Guo China 15 340 0.7× 349 1.0× 63 0.3× 90 0.8× 83 0.8× 30 744
Afsal Kolloli United States 13 276 0.6× 185 0.5× 53 0.2× 130 1.1× 152 1.5× 31 522
YR Mahida United Kingdom 12 120 0.3× 155 0.4× 177 0.8× 61 0.5× 165 1.6× 24 701
Min Soo Han China 15 189 0.4× 220 0.6× 75 0.3× 118 1.0× 119 1.2× 52 559
Aram Yegiazaryan United States 9 225 0.5× 215 0.6× 53 0.2× 34 0.3× 66 0.7× 11 385
Michael de Vera United States 11 128 0.3× 198 0.5× 125 0.5× 147 1.2× 148 1.5× 19 683
Douglas L. Hurley United States 13 198 0.4× 174 0.5× 115 0.5× 85 0.7× 31 0.3× 22 527
Diana Dlugovitzky Argentina 12 371 0.8× 300 0.8× 135 0.6× 215 1.8× 59 0.6× 20 545

Countries citing papers authored by Naihui Chu

Since Specialization
Citations

This map shows the geographic impact of Naihui Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naihui Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naihui Chu more than expected).

Fields of papers citing papers by Naihui Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naihui Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naihui Chu. The network helps show where Naihui Chu may publish in the future.

Co-authorship network of co-authors of Naihui Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Naihui Chu. A scholar is included among the top collaborators of Naihui Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naihui Chu. Naihui Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qingfeng, Jun Wang, Jing Wang, et al.. (2025). New All-Oral Short-term Regimen for Multidrug-Resistant Tuberculosis: A Semi-randomized Controlled Trial Conducted in China. Open Forum Infectious Diseases. 12(2). ofaf020–ofaf020. 1 indexed citations
2.
Chu, Naihui, et al.. (2025). Safety and Tolerability of Contezolid Versus Linezolid for Short-Term Treatment of Rifampicin-Resistant Pulmonary Tuberculosis: A Randomized Controlled Study. Infection and Drug Resistance. Volume 18. 3307–3315. 2 indexed citations
3.
Zhang, Shaoyan, Lei Qiu, Shun-Xian Zhang, et al.. (2024). Efficacy and Safety of Bufei Jiedu Granules in Treating Multidrug-Resistant Pulmonary Tuberculosis: A Multi-center, Double-Blinded and Randomized Controlled Trial. Chinese Journal of Integrative Medicine. 30(7). 579–587. 1 indexed citations
4.
Gao, Shan, et al.. (2023). Antibacterial activity of the novel compound Sudapyridine (WX-081) against Mycobacterium abscessus. Frontiers in Cellular and Infection Microbiology. 13. 1217975–1217975. 3 indexed citations
5.
Shang, Yuanyuan, Suting Chen, Wenhui Shi, et al.. (2023). Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients. Journal of Global Antimicrobial Resistance. 33. 294–300. 4 indexed citations
6.
Liu, Zhifeng, et al.. (2023). Diagnostic value of a nanopore sequencing assay of bronchoalveolar lavage fluid in pulmonary tuberculosis. BMC Pulmonary Medicine. 23(1). 77–77. 16 indexed citations
7.
Wang, Jun, et al.. (2023). Clinical Utility of Contezolid-Containing Regimens in 25 Cases of Linezolid-Intolerable Tuberculosis Patients. Infection and Drug Resistance. Volume 16. 6237–6245. 10 indexed citations
8.
Ma, Yan, Xinyu Ji, Hui Jiang, et al.. (2023). A study of risk factors for tuberculous meningitis among patients with tuberculosis in China: An analysis of data between 2012 and 2019. Frontiers in Public Health. 10. 1040071–1040071. 9 indexed citations
9.
10.
Li, Wensheng, Weibi Chen, Qi Sun, et al.. (2022). Identification of protein biomarkers in host cerebrospinal fluid for differential diagnosis of tuberculous meningitis and other meningitis. Frontiers in Neurology. 13. 886040–886040. 6 indexed citations
11.
Zhou, Wenqiang, Qingfeng Wang, Wenhui Shi, et al.. (2022). Linezolid Pharmacokinetics/Pharmacodynamics-Based Optimal Dosing for Multidrug-Resistant Tuberculosis. International Journal of Antimicrobial Agents. 59(6). 106589–106589. 4 indexed citations
12.
Chen, Suting, Yuanyuan Shang, Guanglu Jiang, et al.. (2021). Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP) Exhibits Direct Antibacterial Activity Against Mycobacterium abscessus. Infection and Drug Resistance. Volume 14. 1199–1208. 8 indexed citations
13.
Jing, Wei, Zhaojing Zong, Bo‐Hao Tang, et al.. (2020). Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China. Antimicrobial Agents and Chemotherapy. 64(3). 25 indexed citations
14.
Wang, Jun, Wei Jing, Wenhui Shi, et al.. (2020). Value of serum cytokine biomarkers TNF-α, IL-4, sIL-2R and IFN-γ for use in monitoring bacterial load and anti-tuberculosis treatment progress. SHILAP Revista de lepidopterología. 2(2). 100028–100028. 11 indexed citations
15.
Wen, Shu’an, Wei Jing, Tingting Zhang, et al.. (2019). Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis. European Journal of Clinical Microbiology & Infectious Diseases. 38(7). 1293–1296. 39 indexed citations
16.
An, Jun, Mengqiu Gao, Naihui Chu, et al.. (2018). Antituberculosis drug prescribing for inpatients in a national tuberculosis hospital in China, 2011–2015. Journal of Global Antimicrobial Resistance. 14. 17–22. 3 indexed citations
17.
18.
Duan, Hongfei, Qingfeng Wang, Jing Wang, et al.. (2016). Clinical Significance of Nontuberculous Mycobacteria Isolated From Respiratory Specimens in a Chinese Tuberculosis Tertiary Care Center. Scientific Reports. 6(1). 36299–36299. 20 indexed citations
19.
Chen, Suting, Yuanyuan Shang, Qian Liang, et al.. (2015). [Detection of mutations in the gyrA and gyrB genes associated with fluoroquinolone-resistance among clinical isolates of Mycobacterium abscessus in China].. PubMed. 38(7). 507–10. 1 indexed citations
20.
Wang, Binbin, Meng Du, Jing Wang, et al.. (2011). Genetic association of polymorphism rs1333049 with gout. Lara D. Veeken. 50(9). 1559–1561. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideo Ogata Breakdown of academic impact, for papers by Yaling Guo Breakdown of academic impact, for papers by Afsal Kolloli Breakdown of academic impact, for papers by YR Mahida Breakdown of academic impact, for papers by Min Soo Han Breakdown of academic impact, for papers by Aram Yegiazaryan Breakdown of academic impact, for papers by Michael de Vera Breakdown of academic impact, for papers by Douglas L. Hurley Breakdown of academic impact, for papers by Diana Dlugovitzky
Rankless by CCL
2026